Deep learning-driven TCRβ repertoire analysis enhances diagnosis and enables mining of immunological biomarkers in systemic lupus erythematosus.
Source check: Source checked. Not independent scientific confirmation.
Finding: DeepTAPE classifies SLE from TCRβ CDR3 sequences and the abstract reports disease-activity and biomarker analyses on patient data; the claim is diagnostic/biomarker discovery, not clinical benefit. The result is reported in BioData Mining. Affiliation was not available in checked primary metadata; no organization is assigned. The study does not establish generalization beyond its reported setting or prospective real-world benefit. Affiliation was not stated in the reviewed material.
Technology: DeepTAPE applies a deep-learning model to T-cell receptor beta-chain CDR3 sequences to classify systemic lupus erythematosus and analyze disease activity and associated biomarkers.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- DeepTAPE applies a deep-learning model to T-cell receptor beta-chain CDR3 sequences to classify systemic lupus erythematosus and analyze disease activity and associated biomarkers.
- Test and result
- DeepTAPE classifies SLE from TCRβ CDR3 sequences and the abstract reports disease-activity and biomarker analyses on patient data; the claim is diagnostic/biomarker discovery, not clinical benefit.
- Limitation / still unknown
- Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s13040-025-00490-5
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.